A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
Orca Bio has disclosed $250 million in funding, flooding its balance sheet with cash to buoy preparations for the ...
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...
News-Medical.Net on MSN
Recent advances in CAR-NK cell therapy could revolutionze cancer treatment
Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, ...
Fox Chase Cancer Center and Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced that ...
In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...
The Brighterside of News on MSN
New study provides a key breakthrough in cancer therapy and synthetic biology
Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics.
A team of cancer biologists led by Princeton’s Yibin Kang has resolved a confounding paradox about retinoids and cancer cells ...
Chimeric antigen receptor natural killer (CAR-NK) cell therapy is emerging as a promising next-generation immunotherapy with ...
News Medical on MSN
Liquid Biopsies Boost Lung Cancer Mutation Detection
In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...
Morning Overview on MSN
New research links cancer therapy and synthetic biology in a major leap
Cancer therapy and synthetic biology are converging around a shared problem that has long frustrated oncologists and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback